Moderna (MRNA) Non-Current Assets (2017 - 2026)
Moderna (MRNA) recorded Non-Current Assets of $5.15 billion in Q2 2026, down 11.9% from $5.84 billion a year earlier and down 10.0% from the prior quarter.
Moderna (MRNA) Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Moderna reported Non-Current Assets of $5.79 billion, down 4.1% from FY2024.
- Annual Non-Current Assets has declined for three straight years, though with a five-year compound annual growth rate of 41.0% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $6.04 billion in FY2024 (-25.4%), $8.1 billion in FY2023 (-34.8%), $12.43 billion in FY2022 (+44.5%) and $8.6 billion in FY2021 (+727.5%).
- The Q2 2026 figure is the lowest quarterly Non-Current Assets since Q1 2021.
- On a year-over-year basis, Non-Current Assets has declined for 13 consecutive quarters, with an average decline of 13.0% over the last eight quarters.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 727.5% in Q4 2021, against a decline of 46.7% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.72 billion (Q1 2026), $5.79 billion (Q4 2025) and $5.54 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Moderna | 100.92 Bn | 80.27 Bn | 52.00 Mn | 5.15 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.15 Bn |
| Mar 31, 2026 | 5.72 Bn |
| Dec 31, 2025 | 5.79 Bn |
| Sep 30, 2025 | 5.54 Bn |
| Jun 30, 2025 | 5.84 Bn |
| Mar 31, 2025 | 5.94 Bn |
| Dec 31, 2024 | 6.04 Bn |
| Sep 30, 2024 | 6.14 Bn |
| Jun 30, 2024 | 6.02 Bn |
| Mar 31, 2024 | 7.13 Bn |
| Dec 31, 2023 | 8.10 Bn |
| Sep 30, 2023 | 8.65 Bn |
| Jun 30, 2023 | 11.29 Bn |
| Mar 31, 2023 | 12.00 Bn |
| Dec 31, 2022 | 12.43 Bn |
| Sep 30, 2022 | 11.76 Bn |
| Jun 30, 2022 | 12.48 Bn |
| Mar 31, 2022 | 11.26 Bn |
| Dec 31, 2021 | 8.60 Bn |
| Sep 30, 2021 | 7.50 Bn |
Moderna Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=MRNA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();